Detailed answers about NEXT CLINICAL RESEARCH ORGANISATION LIMITED, including incorporation, status, business activity, and accounts information.
When was NEXT CLINICAL RESEARCH ORGANISATION LIMITED founded?
NEXT CLINICAL RESEARCH ORGANISATION LIMITED was officially incorporated on 2 February 2015 and is registered under company number 09418105. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is NEXT CLINICAL RESEARCH ORGANISATION LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of NEXT CLINICAL RESEARCH ORGANISATION LIMITED?
NEXT CLINICAL RESEARCH ORGANISATION LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does NEXT CLINICAL RESEARCH ORGANISATION LIMITED do?
NEXT CLINICAL RESEARCH ORGANISATION LIMITED operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is NEXT CLINICAL RESEARCH ORGANISATION LIMITED's registered address?
The registered office address of NEXT CLINICAL RESEARCH ORGANISATION LIMITED is 47 THE RIDGEWAY, FRIERN BARNET, LONDON, ENGLAND, N11 3LG. This is the official address filed with Companies House for legal and statutory correspondence.
Is NEXT CLINICAL RESEARCH ORGANISATION LIMITED financially stable?
The most recent accounts for NEXT CLINICAL RESEARCH ORGANISATION LIMITED were made up to 31 December 2024, filed as MICRO ENTITY. Next accounts are due by 30 September 2026.